title: Genome editing of human pluripotent stem cells to generate human cellular disease models.
abstract: Disease modeling with human pluripotent stem cells has come into the public spotlight with the awarding of the Nobel Prize in Physiology or Medicine for 2012 to Drs John Gurdon and Shinya Yamanaka for the discovery that mature cells can be reprogrammed to become pluripotent. This discovery has opened the door for the generation of pluripotent stem cells from individuals with disease and the differentiation of these cells into somatic cell types for the study of disease pathophysiology. The emergence of genome-editing technology over the past few years has made it feasible to generate and investigate human cellular disease models with even greater speed and efficiency. Here, recent technological advances in genome editing, and its utility in human biology and disease studies, are reviewed.
authors.affiliation: Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA. kiranmusunuru@gmail.com
authors.forename: Kiran
authors.initials: K
authors.lastname: Musunuru
mesh_terms: D002454:Cell Differentiation / Q000235:genetics; D004194:Disease / Q000235:genetics*; D015894:Genome, Human / Q000235:genetics*; D023281:Genomics; D006801:Humans; D008954:Models, Biological; D039904:Pluripotent Stem Cells / Q000378:metabolism*